Le Lézard
Classified in: Health, Science and technology

ProPhotonix Launches New UV Laser Modules

SALEM, N.H., Jan. 27, 2022 /PRNewswire-PRWeb/ -- ProPhotonix Limited, a designer and manufacturer of LED illumination systems and laser diode modules with operations in Ireland and the United Kingdom, is pleased to announce the addition of a new 375nm laser to its Photon laser modules range. As a laser diode distributor as well as a laser module manufacturer, ProPhotonix has access to the latest in laser diode technology and has developed this new UV Photon laser module to address the increasing interest in UV lasers including applications such as UV curing and Particle measurement.

The UV Photon laser is a 375nm laser available in power levels up to 70mW and is well suited to UV curing applications that require fast curing from a very focused UV light. 3D Printing applications, many of which currently use 405nm lasers, could benefit from this compact 375nm laser. The shorter wavelength allows the use of resins which are not as light sensitive, reducing waste and the need to shield the resin from environmental light to prevent accidental curing. The laser also has the potential to take particle analysis applications to another level with the shorter wavelength allowing even smaller particles to be detected and measured.

With many thousands of Photon laser modules operating successfully in the field, and a wide range of optical options as well as CW and modulation options, the Photon laser modules are compact, reliable, and configurable to address a wide range of applications. Now available with adjustable optics as well as an enhanced boresight option, the platform offers easy integration as a final product or an ideal evaluation product should you need to validate laser technology within your system. ProPhotonix can partner with you to develop a customized laser module should your application have more specific requirements.

Jeremy Lane, Managing Director of ProPhotonix UK, said "We are pleased to add this new UV option to the Photon laser platform. We believe the new 375nm wavelength combined with the reliability and configurability of the Photon laser platform offers OEMs a straightforward solution to integrate or evaluate UV lasers in their systems, enhancing their system performance."

For more information, visit: https://bit.ly/3H2UkOZ


Jeremy Lane, Managing Director,
ProPhotonix Limited

Tel: +44 (0) 1279 717170

[email protected]

About ProPhotonix

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at http://www.prophotonix.com.

Media Contact

AOIFE CHAPMAN, PROPHOTONIX, +353 215001300, [email protected]


These press releases may also interest you

at 19:18
Franchise Global Health Inc. ("Franchise Global" or the "Company")  (FRA: WV4A) is pleased to announce its results for the first quarter of 2022. "The Company's German reportable segment experienced strong sales and gross profit through the first...

at 19:06
Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection, will present updates at the 2022 annual meeting of the American Society for Clinical Oncology (ASCO) in Chicago...

at 19:05
St. Croix Hospice is proud to have earned four Gold and three Silver Aster Awards in the Home Health/Hospice group for marketing and communications materials created in 2021. The Aster Awards by Creative Images honor "excellence in healthcare...

at 18:59
Brookdale Senior Living Inc. ("Brookdale" or the "Company") announced today that Lucinda "Cindy" Baier, President and Chief Executive Officer will participate in the Jefferies Healthcare Conference Thursday, June 9, 2022. ...

at 18:36
Today, the Public Health Agency of Canada (PHAC) is confirming additional cases of monkeypox in Canada. In addition to the previously reported sixteen confirmed cases in Quebec, PHAC's National Microbiology Laboratory (NML) has confirmed another 10...

at 18:28
Cantargia (Cantargia AB) today reported extended interim results in first-line pancreatic cancer (PDAC) patients treated with nadunolimab (CAN04) in combination with gemcitabine and nab-paclitaxel in the phase I/IIa CANFOUR trial. The efficacy was...

News published on 27 january 2022 at 02:00 and distributed by: